Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-25

FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for lurasidone hydrochloride by Heritage Pharma Labs (Avet) under an ANDA, enabling continued or expanded generic access…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lurasidone hydrochloride (Lurasidone hydrochloride)

Snippet

SUPPL AP for LURASIDONE HYDROCHLORIDE (LURASIDONE HYDROCHLORIDE)